Study finds Avastin and Lucentis are equally effective in treating AMD
Thursday, April 28, 2011 - 12:01
in Health & Medicine
Researchers are reporting results from the first year of a two-year clinical trial that Avastin, a drug approved to treat some cancers and that is commonly used off-label to treat age-related macular degeneration (AMD), is as effective as the Food and Drug Administration-approved drug Lucentis for the treatment of AMD.